NANOGUN TECHNOLOGY
Chambly
About NANOGUN TECHNOLOGY
Développement d'un anticancéreux appelé IMDENDRIM (complexe de nanoparticules : dendrimères) pour traiter les tumeurs solides
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Non-Equity Assistance (Dec 2021)
Canonical: https://fsome.com/organization/nanogun-technology-716967 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.